Search - tctmd.com

Displaying 241 - 260 of 2101

Sort: Relevancy | Date

Presentation NY Valves 2024

Pro: Echocardiographic Assessment Is Still the "Gold Standard" for AR

Presenter: Aarti Patil

June 06, 2024

Presentation NY Valves 2024

Advances in Imaging for SHD: Icing on the Cake or True Need?

Presenter: Scott M. Chadderdon

June 06, 2024

Presentation NY Valves 2024

ICE Imaging, as an Imaging Modality

Presenter: Chad Alan Kliger

June 06, 2024

Presentation NY Valves 2024

4D ICE Imaging of the Tricuspid Valve

Presenter: Lucy Michelle Safi

June 06, 2024

Presentation NY Valves 2024

4D ICE Imaging of the Mitral Valve

Presenter: Vaikom S. Mahadevan

June 06, 2024

Presentation NY Valves 2024

4D ICE imaging of the Left Atrial Appendage and New Frontiers in EP

Presenter: Devi G. Nair

June 06, 2024

Presentation NY Valves 2024

Lead Management Considerations in TR Patients

Presenter: Laurence Epstein

June 06, 2024

Presentation NY Valves 2024

Surgery Outcomes and Indications

Presenter: Robert L. Smith

June 06, 2024

Presentation NY Valves 2024

The Importance of Patient Reported Outcomes in TR Clinical Studies

Presenter: Suzanne V. Arnold

June 06, 2024

Presentation NY Valves 2024

A Concise Overview of Right Heart Physiology and Relevance to TR Management

Presenter: Michael I. Brener

June 06, 2024

Presentation NY Valves 2024

Integrating Tricuspid Valve Anatomy and Imaging (Diagnostic and Intraprocedure)

Presenter: Paul A. Grayburn

June 06, 2024

Presentation NY Valves 2024

Natural History and New Classification of TR Phenotypes

Presenter: Anna Sannino

June 06, 2024

Presentation NY Valves 2024

First-in-Human Clinical Trial of a Robotic TEE System for Diagnostics and Interventional Guidance (ROB'E)

Presenter: Jury Schewel

June 05, 2024

Presentation NY Valves 2024

AI-Powered Robotically Assisted Imaging Solutions for Cardiovascular Interventions (Laza Medical)

Presenter: Edwin Ho

June 05, 2024

Presentation NY Valves 2024

AI-Powered Cardiac Ultrasound Improves Identification of High-Risk Aortic Stenosis (EchoIQ)

Presenter: Pedro Covas

June 05, 2024

Presentation NY Valves 2024

Keynote Lecture: AI-Powered Multimodality Cardiac Imaging in Valvular Heart Disease: From Screening to Intervention

Presenter: Partho P. Sengupta

June 05, 2024

Presentation NY Valves 2024

TR: Diagnosis, Severity, Risk Stratification, and Management Based on Imaging

Presenter: Fabien Praz

June 05, 2024

Presentation NY Valves 2024

Moderate AS: Diagnosis, Risk Stratification, Current Management, and Ongoing Trials

Presenter: Philippe Pibarot

June 05, 2024

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

Presentation EuroPCR 2024

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Presenter: Danny Dvir

May 15, 2024

Advertisement

Pro: Echocardiographic Assessment Is Still the "Gold Standard" for AR

Advances in Imaging for SHD: Icing on the Cake or True Need?

ICE Imaging, as an Imaging Modality

4D ICE Imaging of the Tricuspid Valve

4D ICE Imaging of the Mitral Valve

4D ICE imaging of the Left Atrial Appendage and New Frontiers in EP

Lead Management Considerations in TR Patients

Surgery Outcomes and Indications

The Importance of Patient Reported Outcomes in TR Clinical Studies

A Concise Overview of Right Heart Physiology and Relevance to TR Management

Integrating Tricuspid Valve Anatomy and Imaging (Diagnostic and Intraprocedure)

Natural History and New Classification of TR Phenotypes

First-in-Human Clinical Trial of a Robotic TEE System for Diagnostics and Interventional Guidance (ROB'E)

AI-Powered Robotically Assisted Imaging Solutions for Cardiovascular Interventions (Laza Medical)

AI-Powered Cardiac Ultrasound Improves Identification of High-Risk Aortic Stenosis (EchoIQ)

Keynote Lecture: AI-Powered Multimodality Cardiac Imaging in Valvular Heart Disease: From Screening to Intervention

TR: Diagnosis, Severity, Risk Stratification, and Management Based on Imaging

Moderate AS: Diagnosis, Risk Stratification, Current Management, and Ongoing Trials

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content